Short Interest in Aptorum Group Limited (NASDAQ:APM) Declines By 58.4%

Aptorum Group Limited (NASDAQ:APM) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 41,000 shares, a drop of 58.4% from the March 31st total of 98,500 shares. Currently, 1.9% of the company’s shares are short sold. Based on an average daily trading volume, of 2,340,000 shares, the short-interest ratio is currently 0.0 days.

Aptorum Group Trading Down 3.6 %

NASDAQ:APM traded down $0.20 during midday trading on Friday, reaching $5.28. The company had a trading volume of 27,222 shares, compared to its average volume of 67,494. The stock’s fifty day simple moving average is $6.25 and its 200-day simple moving average is $3.38. Aptorum Group has a 12-month low of $1.35 and a 12-month high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.